Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration
Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration
About this item
Full title
Author / Creator
Publisher
England: Taylor & Francis
Journal title
Language
English
Formats
Publication information
Publisher
England: Taylor & Francis
Subjects
More information
Scope and Contents
Contents
Intravenously administered for the treatment of rectum cancer, irinotecan produces severe side effects due to very high plasma concentrations. A novel irinotecan-encapsulated double reverse thermosensitive nanocarrier system (DRTN) for rectal administration was developed as an alternative. The DRTN was fabricated by dispersing the thermosensitive i...
Alternative Titles
Full title
Irinotecan-encapsulated double-reverse thermosensitive nanocarrier system for rectal administration
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_2195238374
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2195238374
Other Identifiers
ISSN
1071-7544
E-ISSN
1521-0464
DOI
10.1080/10717544.2016.1272651
